GlassScriptPhysician profile
Peggy Mentor
NPI 1023006525
$1,662.18
in general payments reported to CMS, 2019-2025
20 companies · $371 in 2025
The $371 reported for 2025 was more than what 77% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $338 · 2021: $556 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $340.72 | 2019-2021 | |
| Axsome Therapeutics, INC. | $278.13 | 2025 | Auvelity |
| Lilly USA, LLC | $139.96 | 2019-2021 | |
| Acadia Pharmaceuticals INC | $124.00 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $112.87 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $89.23 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $82.48 | 2019 | |
| Acorda Therapeutics, INC | $78.50 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $67.09 | 2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $50.19 | 2021 | |
| Amarin Pharma, INC. | $43.20 | 2020 | |
| Biogen, INC. | $39.75 | 2021 | |
| Avanir Pharmaceuticals, INC. | $38.99 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $36.47 | 2020-2021 | |
| Mdd US Operations, LLC | $32.45 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $25.82 | 2025 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $25.72 | 2021 | |
| Kyowa Kirin, INC. | $23.71 | 2021 | |
| Amneal Pharmaceuticals LLC | $19.11 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peggy Mentor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.